Evidence map›Paper›PMID 42499528›Full record

ReviewBioactive materials2026

Tissue engineering for traumatic spinal cord injury: Research advances and clinical translation.

Chengcheng Luan, Dong Ming, Xiaosong Gu

Abstract readReview
In one paragraph

Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chengcheng LuanAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300000, China.
Dong MingAcademy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, 300000, China.
Xiaosong GuKey Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Center of Neuroregeneration, Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Nantong University, Nantong, 226001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic spinal cord injury (TSCI) typically leads to persistent motor and sensory deficits. Interdisciplinary advances have supported preclinical research into tissue engineering approaches for TSCI repair, with the core objective of reconstructing damaged neural tissue and restoring both anatomical integrity and physiological neural function. Many published reviews provide only a descriptive categorization of biomaterials, without establishing a systematic design logic aligned with stepwise pathological shifts after TSCI. This review summarizes tissue engineering interventions for TSCI and develops a biomaterial design system tailored to distinct phases of pathological injury. It elucidates intrinsic connections among material structure, physicochemical properties, and in vivo biological performance. This work further examines appropriate animal model selection and practical hurdles that restrict the bench-to-clinic translation of preclinical therapeutic effects. Finally, it identifies key bottlenecks hindering clinical translation and provides theoretical ideas for the development of neural regenerative biomaterials and the translational research of TSCI repair.

Indexed as

Clinical translationNeural regenerationPathology-guided biomaterial designTissue engineeringTraumatic spinal cord injury

Identifiers

PMID42499528
PMCPMC13396627

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.